Showing 19,861 - 19,880 results of 65,148 for search '(( 59 nn decrease ) OR ( 5 ((fold decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 1.23s Refine Results
  1. 19861

    Study eligibility and search terms. by Kalpana Raghunathan (15997153)

    Published 2024
    “…Identified barriers and enablers aligned to five main themes related to the contextual level of impact: (i) healthcare system and systemic factors, (ii) patient and population, (iii) guidelines and standards, (iv) organisational capacity, and (v) health professional practice.…”
  2. 19862

    Example of coding and theme development. by Kalpana Raghunathan (15997153)

    Published 2024
    “…Identified barriers and enablers aligned to five main themes related to the contextual level of impact: (i) healthcare system and systemic factors, (ii) patient and population, (iii) guidelines and standards, (iv) organisational capacity, and (v) health professional practice.…”
  3. 19863

    Summary of studies reviewed. by Kalpana Raghunathan (15997153)

    Published 2024
    “…Identified barriers and enablers aligned to five main themes related to the contextual level of impact: (i) healthcare system and systemic factors, (ii) patient and population, (iii) guidelines and standards, (iv) organisational capacity, and (v) health professional practice.…”
  4. 19864

    Changes in HbA<sub>1c</sub> levels (%) from baseline in response to three weeks at the DRC. by Helmuth Haslacher (402495)

    Published 2019
    “…<p>[a] Dependence of relative improvement on initial HbA<sub>1c</sub> concentration; [b] individual changes in HbA<sub>1c</sub>: vertical lines denote the respective changes in HbA<sub>1c</sub> incurred at discharge (vs. at admission) by single patients with type 2 diabetes, and black circles values reached at discharge showing 27% to stay below and 8% to reach an HbA<sub>1c</sub> <6.5%, while in 11% HbA<sub>1c</sub> decreased to <7.0%, i.e. to therapeutic target. …”
  5. 19865

    Data_Sheet_1_Longer Neurophysiological vs. Clinical Recovery Following Sport Concussion.pdf by Michail Ntikas (11815844)

    Published 2021
    “…All participants completed the SCAT5 and underwent TMS to assess cortical silent period duration (CSp), a measure of intracortical inhibition.…”
  6. 19866
  7. 19867

    Clinical patient characteristics. by Harm J. van der Horn (3700717)

    Published 2023
    “…After measuring the Big Five personality dimensions, principal component analysis (PCA) was used to obtain a superordinate factor representing emotional instability, consisting of high Neuroticism, moderate Openness, and low Extraversion, Agreeableness, and Conscientiousness. …”
  8. 19868
  9. 19869
  10. 19870
  11. 19871

    Size of PPS and slope of its boundary is modulated by FN, Δ<i>T</i> and <i>σ</i><sub><i>v</i></sub>. by Zdenek Straka (13794488)

    Published 2022
    “…Except for <i>σ</i><sub><i>v</i></sub>, Δ<i>T</i>, <i>FN</i> and <i>σ</i><sub><i>x</i></sub> = 0<i>cm</i>, the baseline parameters (see <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1010464#pcbi.1010464.t001" target="_blank">Table 1</a>) were used. …”
  12. 19872

    S1 Dataset - by Gui-Hong Zhang (9284601)

    Published 2023
    “…Tβ4 alleviated oxidative damage by reducing MDA, LDH and ROS and increasing SOD and GSH-PX in Aβ-treated SH-SY5Y cells. We found that Tβ4 inhibit ERK/p38 MAPK pathway and intensify the expression of 5-HTR1A. …”
  13. 19873

    Image_5_Breathing Abnormalities During Sleep and Wakefulness in Rett Syndrome: Clinical Relevance and Paradoxical Relationship With Circulating Pro-oxidant Markers.pdf by Silvia Leoncini (383432)

    Published 2022
    “…</p>Methods<p>Female patients with a clinical diagnosis of typical RTT (n = 66), MECP2 gene mutation, and apneas were enrolled (mean age: 12.5 years). …”
  14. 19874

    PCR Primers. by Laura Bellassen (22209109)

    Published 2025
    “…Together, these results identify SLAMF5 as a key regulator of myeloid cell activation in neuroinflammation and suggest that it may represent a promising therapeutic target for autoimmune disorders such as MS.…”
  15. 19875

    Suggested model. by Laura Bellassen (22209109)

    Published 2025
    “…Together, these results identify SLAMF5 as a key regulator of myeloid cell activation in neuroinflammation and suggest that it may represent a promising therapeutic target for autoimmune disorders such as MS.…”
  16. 19876

    Mouse antibodies. by Laura Bellassen (22209109)

    Published 2025
    “…Together, these results identify SLAMF5 as a key regulator of myeloid cell activation in neuroinflammation and suggest that it may represent a promising therapeutic target for autoimmune disorders such as MS.…”
  17. 19877

    Human antibodies. by Laura Bellassen (22209109)

    Published 2025
    “…Together, these results identify SLAMF5 as a key regulator of myeloid cell activation in neuroinflammation and suggest that it may represent a promising therapeutic target for autoimmune disorders such as MS.…”
  18. 19878
  19. 19879

    DataSheet_1_Functional variant rs12614 in CFB confers a low risk of IgA nephropathy by attenuating complement alternative pathway activation in Han Chinese.pdf by Dian-Chun Shi (13951020)

    Published 2022
    “…Furthermore, in vitro study revealed that rs12614-T decreased the expression of CFB and reduced its binding affinity to C3b by four-fold compared with rs12614-C. …”
  20. 19880

    DataSheet_1_Functional variant rs12614 in CFB confers a low risk of IgA nephropathy by attenuating complement alternative pathway activation in Han Chinese.pdf by Dian-Chun Shi (13951020)

    Published 2022
    “…Furthermore, in vitro study revealed that rs12614-T decreased the expression of CFB and reduced its binding affinity to C3b by four-fold compared with rs12614-C. …”